Adams J (2004) The proteasome: a suitable antineoplastic target. Nat Rev Cancer 4(5):349–360
Article
CAS
PubMed
Google Scholar
Afaq F et al (2003) Inhibition of ultraviolet B-mediated activation of nuclear factor kappaB in normal human epidermal keratinocytes by green tea constituent (−)-epigallocatechin-3-gallate. Oncogene 22(7):1035–1044
Article
CAS
PubMed
Google Scholar
Ahmed RS et al (2016) Biological and mechanistic characterization of novel prodrugs of green tea polyphenol epigallocatechin gallate analogs in human leiomyoma cell lines. J Cell Biochem 117(10):2357–2369
Article
CAS
PubMed
Google Scholar
Axelrod J, Tomchick R (1958) Enzymatic O-methylation of epinephrine and other catechols. J Biol Chem 233(3):702–705
CAS
PubMed
Google Scholar
Chen D et al (2008) Tea polyphenols, their biological effects and potential molecular targets. Histol Histopathol 23(4):487–496
PubMed
PubMed Central
Google Scholar
Chen D et al (2011) EGCG, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatment. Adv Clin Chem 53:155–177
Article
CAS
PubMed
PubMed Central
Google Scholar
Chen D et al (2012) Novel epigallocatechin gallate (EGCG) analogs activate AMP-activated protein kinase pathway and target cancer stem cells. Bioorg Med Chem 20(9):3031–3037
Article
CAS
PubMed
PubMed Central
Google Scholar
Chiou YS et al (2012) Peracetylated (−)-epigallocatechin-3-gallate (AcEGCG) potently suppresses dextran sulfate sodium-induced colitis and colon tumorigenesis in mice. J Agric Food Chem 60(13):3441–3451
Article
CAS
PubMed
Google Scholar
Chiou YS et al (2013) Peracetylated (−)-epigallocatechin-3-gallate (AcEGCG) potently prevents skin carcinogenesis by suppressing the PKD1-dependent signaling pathway in CD34+ skin stem cells and skin tumors. Carcinogenesis 34(6):1315–1322
Article
CAS
PubMed
Google Scholar
Dawling S et al (2001) Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens. Cancer Res 61(18):6716–6722
CAS
PubMed
Google Scholar
Dou QP (2009) Molecular mechanisms of green tea polyphenols. Nutr Cancer 61(6):827–835
Article
CAS
PubMed
PubMed Central
Google Scholar
Dou QP, Zonder JA (2014) Overview of proteasome inhibitor-based anti-cancer therapies: perspective on bortezomib and second generation proteasome inhibitors versus future generation inhibitors of ubiquitin-proteasome system. Curr Cancer Drug Targets 14(6):517–536
Article
CAS
PubMed
PubMed Central
Google Scholar
Dou QP et al (2008) Green tea polyphenols as a natural tumour cell proteasome inhibitor. Inflammopharmacology 16(5):208–212
Article
CAS
PubMed
PubMed Central
Google Scholar
Downes E et al (2010) The burden of uterine fibroids in five European countries. Eur J Obstet Gynecol Reprod Biol 152(1):96–102
Article
PubMed
Google Scholar
Du G-J et al (2012) Epigallocatechin gallate (EGCG) is the most effective cancer chemopreventive polyphenol in green tea. Nutrients 4(11):1679–1691
Article
CAS
PubMed
PubMed Central
Google Scholar
Forester SC, Lambert JD (2014) Synergistic inhibition of lung cancer cell lines by (−)-epigallocatechin-3-gallate in combination with clinically used nitrocatechol inhibitors of catechol-O-methyltransferase. Carcinogenesis 35(2):365–372
Article
CAS
PubMed
Google Scholar
Hu J, Zhou D, Chen Y (2009) Preparation and antioxidant activity of green tea extract enriched in epigallocatechin (EGC) and epigallocatechin gallate (EGCG). J Agric Food Chem 57(4):1349–1353
Article
CAS
PubMed
Google Scholar
Hussain AR et al (2012) Cross-talk between NFkB and the PI3-kinase/AKT pathway can be targeted in primary effusion lymphoma (PEL) cell lines for efficient apoptosis. PLoS One 7(6):e39945
Article
CAS
PubMed
PubMed Central
Google Scholar
Islam MS et al (2014) Use of dietary phytochemicals to target inflammation, fibrosis, proliferation, and angiogenesis in uterine tissues: promising options for prevention and treatment of uterine fibroids? Mol Nutr Food Res 58(8):1667–1684
Article
CAS
PubMed
PubMed Central
Google Scholar
Johnson JJ, Bailey HH, Mukhtar H (2010) Green tea polyphenols for prostate cancer chemoprevention: a translational perspective. Phytomedicine 17(1):3–13
Article
CAS
PubMed
PubMed Central
Google Scholar
Kanwar J et al (2012) Recent advances on tea polyphenols. Front Biosci (Elite Ed) 4:111–131
Article
Google Scholar
Lam WH et al (2004) A potential prodrug for a green tea polyphenol proteasome inhibitor: evaluation of the peracetate ester of (−)-epigallocatechin gallate [(−)-EGCG]. Bioorg Med Chem 12(21):5587–5593
Article
CAS
PubMed
Google Scholar
Lambert JD et al (2006) Peracetylation as a means of enhancing in vitro bioactivity and bioavailability of epigallocatechin-3-gallate. Drug Metab Dispos 34(12):2111–2116
Article
CAS
PubMed
Google Scholar
Landis-Piwowar KR et al (2007a) A novel prodrug of the green tea polyphenol (−)-epigallocatechin-3-gallate as a potential anticancer agent. Cancer Res 67(9):4303–4310
Article
CAS
PubMed
Google Scholar
Landis-Piwowar KR et al (2007b) Methylation suppresses the proteasome-inhibitory function of green tea polyphenols. J Cell Physiol 213(1):252–260
Article
CAS
PubMed
Google Scholar
Larsen CA, Dashwood RH (2010) (−)-Epigallocatechin-3-gallate inhibits Met signaling, proliferation, and invasiveness in human colon cancer cells. Arch Biochem Biophys 501(1):52–57
Article
CAS
PubMed
PubMed Central
Google Scholar
Lee SC et al (2008) Effect of a prodrug of the green tea polyphenol (−)-epigallocatechin-3-gallate on the growth of androgen-independent prostate cancer in vivo. Nutr Cancer 60(4):483–491
Article
CAS
PubMed
Google Scholar
Lin H-K et al (2002) Proteasome activity is required for androgen receptor transcriptional activity via regulation of androgen receptor nuclear translocation and interaction with coregulators in prostate cancer cells. J Biol Chem 277(39):36570–36576
Article
CAS
PubMed
Google Scholar
Lu H, Meng X, Yang CS (2003) Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (−)-epigallocatechin gallate. Drug Metab Dispos 31(5):572–579
Article
CAS
PubMed
Google Scholar
Matsuzaki S, Darcha C (2014) Antifibrotic properties of epigallocatechin-3-gallate in endometriosis. Hum Reprod 29(8):1677–1687
Article
CAS
PubMed
Google Scholar
Nam S, Smith DM, Dou QP (2001) Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo. J Biol Chem 276(16):13322–13330
Article
CAS
PubMed
Google Scholar
National Cancer Institute (2018) Cancer statistics. Understanding cancer. Available from: https://www.cancer.gov/about-cancer/understanding/statistics
Ozercan IH et al (2008) Chemoprevention of fibroid tumors by [−]-epigallocatechin-3-gallate in quail. Nutr Res 28(2):92–97
Article
CAS
PubMed
Google Scholar
Park AM, Dong Z (2003) Signal transduction pathways: targets for green and black tea polyphenols. J Biochem Mol Biol 36(1):66–77
PubMed
Google Scholar
Pérez RA et al (1993) Inhibition of catechol-O-methyltransferase by 1-vinyl derivatives of nitrocatechols and nitroguaiacols. Biochem Pharmacol 45(10):1973–1981
Article
PubMed
Google Scholar
Qin J et al (2007) A component of green tea, (−)-epigallocatechin-3-gallate, promotes apoptosis in T24 human bladder cancer cells via modulation of the PI3K/Akt pathway and Bcl-2 family proteins. Biochem Biophys Res Commun 354(4):852–857
Article
CAS
PubMed
Google Scholar
Roshdy E et al (2013) Treatment of symptomatic uterine fibroids with green tea extract: a pilot randomized controlled clinical study. Int J Womens Health 5:477–486
PubMed
PubMed Central
Google Scholar
Sang S et al (2011) The chemistry and biotransformation of tea constituents. Pharmacol Res 64(2):87–99
Article
CAS
PubMed
Google Scholar
Shen M, Chan TH, Dou QP (2012) Targeting tumor ubiquitin-proteasome pathway with polyphenols for chemosensitization. Anti Cancer Agents Med Chem 12(8):891–901
Article
CAS
Google Scholar
Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68(1):7–30
Article
PubMed
Google Scholar
Singh BN, Shankar S, Srivastava RK (2011) Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem Pharmacol 82(12):1807–1821
Article
CAS
PubMed
PubMed Central
Google Scholar
Sparic R (2014) Uterine myomas in pregnancy, childbirth and puerperium. Srp Arh Celok Lek 142(1–2):118–124
Article
PubMed
Google Scholar
Sparic R et al (2016) Epidemiology of uterine myomas: a review. Int J Fertil Steril 9(4):424–435
PubMed
Google Scholar
Styer AK, Rueda BR (2015) The epidemiology and genetics of uterine leiomyoma. Best Pract Res Clin Obstet Gynaecol 34:3–12
Article
PubMed
Google Scholar
Tal R, Segars JH (2014) The role of angiogenic factors in fibroid pathogenesis: potential implications for future therapy. Hum Reprod Update 20(2):194–216
Article
CAS
PubMed
Google Scholar
Tang F-Y, Nguyen N, Meydani M (2003) Green tea catechins inhibit VEGF-induced angiogenesis in vitro through suppression of VE-cadherin phosphorylation and inactivation of Akt molecule. Int J Cancer 106(6):871–878
Article
CAS
PubMed
Google Scholar
Tang S-N et al (2012) EGCG enhances the therapeutic potential of gemcitabine and CP690550 by inhibiting STAT3 signaling pathway in human pancreatic cancer. PLoS One 7(2):e31067
Article
CAS
PubMed
PubMed Central
Google Scholar
Taylor DK, Leppert PC (2012) Treatment for uterine fibroids: searching for effective drug therapies. Drug Discov Today Ther Strateg 9(1):e41–e49
Article
PubMed
PubMed Central
Google Scholar
Van Aller GS et al (2011) Epigallocatechin gallate (EGCG), a major component of green tea, is a dual phosphoinositide-3-kinase/mTOR inhibitor. Biochem Biophys Res Commun 406(2):194–199
Article
PubMed
CAS
Google Scholar
Vyas S et al (2007) Design, semisynthesis, and evaluation of O-acyl derivatives of (−)-epigallocatechin-3-gallate as antitumor agents. J Agric Food Chem 55(15):6319–6324
Article
CAS
PubMed
Google Scholar
Wang YC, Bachrach U (2002) The specific anti-cancer activity of green tea (−)-epigallocatechin-3-gallate (EGCG). Amino Acids 22(2):131–143
Article
PubMed
Google Scholar
Wang H et al (2012) Plants against cancer: a review on natural phytochemicals in preventing and treating cancers and their druggability. Anti Cancer Agents Med Chem 12(10):1281–1305
Article
CAS
Google Scholar
Wang CC et al (2013) Prodrug of green tea epigallocatechin-3-gallate (pro-EGCG) as a potent anti-angiogenesis agent for endometriosis in mice. Angiogenesis 16(1):59–69
Article
CAS
PubMed
Google Scholar
Wise LA et al (2016) History of uterine leiomyoma and risk of endometrial cancer in black women. Cancer Causes Control 27(4):545–552
Article
PubMed
PubMed Central
Google Scholar
World Health Organization (2018) Cancer. Available from: http://www.who.int/news-room/fact-sheets/detail/cancer
Wu AH et al (2003) Tea intake, COMT genotype, and breast cancer in Asian-American women. Cancer Res 63(21):7526–7529
CAS
PubMed
Google Scholar
Xu H et al (2009) Anti-angiogenic effects of green tea catechin on an experimental endometriosis mouse model. Hum Reprod 24(3):608–618
Article
CAS
PubMed
Google Scholar
Yang CS, Wang ZY (1993) Tea and cancer. J Natl Cancer Inst 85(13):1038–1049
Article
CAS
PubMed
Google Scholar
Yang Q, Diamond MP, Al-Hendy A (2016) Early life adverse environmental exposures increase the risk of uterine fibroid development: role of epigenetic regulation. Front Pharmacol 7:40
CAS
PubMed
PubMed Central
Google Scholar
Zaveri NT (2006) Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer applications. Life Sci 78(18):2073–2080
Article
CAS
PubMed
Google Scholar
Zhang Q et al (2006) Green tea extract and (−)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1α protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells. Am Assoc Cancer Res 5(5):1227–1238
CAS
Google Scholar
Zhang D et al (2010a) Antiproliferative and proapoptotic effects of epigallocatechin gallate on human leiomyoma cells. Fertil Steril 94(5):1887–1893
Article
CAS
PubMed
Google Scholar
Zhang D et al (2010b) Green tea extract inhibits proliferation of uterine leiomyoma cells in vitro and in nude mice. Am J Obstet Gynecol 202(3):289.e1–289.e9
Article
CAS
Google Scholar
Zhang G et al (2012) Anti-cancer activities of tea epigallocatechin-3-gallate in breast cancer patients under radiotherapy. Curr Mol Med 12(2):163–176
Article
CAS
PubMed
PubMed Central
Google Scholar